We are live on ! Find out more
SGRX icon

Sangrix

5 hedge funds and large institutions have $25.2K invested in Sangrix in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

67% more funds holding

Funds holding: 3 → 5 (+2)

3.63% less ownership

Funds ownership: 3.9% → 0.27% (-3.6%)

59% less capital inflows, than outflows

Capital inflows: $25.3K | Capital outflows: $62.1K

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SGRX Hedge Fund Activity: Q2 2025 in Review

5 of the 7,632 institutional investors tracked by Wall St. Rank reported a position in Sangrix (SGRX) for Q2 2025, worth a combined $25.2K — down 60% from $63K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SGRX positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $10.5K. The largest seller was Virtu Financial, exiting entirely with an estimated $41K sold.

  • 5 institutional investors held Sangrix (SGRX) as of Q2 2025, up from 3 in Q1 2025.
  • Funds reported $25.2K of Sangrix stock for Q2 2025, down 60% quarter-over-quarter.
  • 4 funds opened new Sangrix positions in Q2 2025 and 2 closed out, a net change of +2 holders.
  • The largest Sangrix buyer in Q2 2025 was UBS Group, an estimated $10.5K added.
  • The largest Sangrix seller in Q2 2025 was Virtu Financial, an estimated $41K sold.

Based on aggregated 13F filings for Q2 2025.